It only costs $10 to make a bottle of insulin. But drug companies charge people hundreds of dollars.
President Biden capped the cost of insulin at $35 a month for seniors on Medicare. Now, @POTUS is calling on Congress to cap this cost for every American.
@zalaly@NatureMedicine@Medscape Bad outcomes by system. There's some stuff, but, honestly, compared to the potential benefits these drugs come out looking like superstars.
@zalaly@NatureMedicine@Medscape Let's start with the good news. GLP1ras were associated with protean benefits (in addition to weight loss): less infection, less schizophrenia, less suicide, less lung disease, less alcohol use disorder, less acute kidney injury (#blesstheirhearts).
We asked a few community members how they would spend a day if type 1 diabetes (T1D) wasn’t a factor. As the leading global T1D research and advocacy organization, we help make everyday life better while driving toward cures. We won’t stop until the day we’re able to make this condition a thing of the past. To learn more about how you can get involved and help us get to that day sooner, visit https://t.co/RmC4lvc5UK
#GivingTuesday
Among 15 million people, Covid vaccination linked to a marked reduction of Type 2 diabetes, compared with unvaccinated or before vaccines were available. Once T2D was manifest, it was durable in >70%
https://t.co/VvTbBD3MLF
Tandem’s new Mobi automated insulin delivery system has received FDA clearance, making it the world’s smallest insulin delivery system to be fully controlled by a smartphone. All the details available here - https://t.co/9sF4anJgI2
It might seem like wearing long robes in high temperatures would make the heat feel worse, but here's what we can all learn from the Bedouin and Tuareg people when it comes to keeping cool
Adults with type 1 diabetes may be able to reduce their diabetes distress through a group-based intervention according to findings from the EMBARK trial presented by @HesslerJones at #ADA2023. @UCSFFamilyMed@ADA_DiabetesPro https://t.co/XTPyk5MYeb
A lot of different issues can cause erectile dysfunction, but — despite assumptions — low testosterone isn’t at the top of the list. Here’s what to know. https://t.co/VsL0IRKXNX
Not every day you see an anti-obesity drug that has an average of >24% body weight loss
🆕 @NEJM#ADA2023
https://t.co/dzh5dKgV8i
Triple receptor agonist weight loss exceeds prior GLP-1 drugs (and dual receptor agents) and has yet to plateau
A diagnosis of #COVID19 in children was associated with an increased incidence of type 1 diabetes since 2020.
The findings suggest that #SARSCoV2 infection contributed to the observed increase in diabetes incidence during the pandemic.
https://t.co/d0zC9K3aCa
An oral robotic pill could be used to deliver teriparatide for #osteoporosis safely with similar or higher drug concentrations that what is delivered through subcutaneous injection, according to findings from a phase 1 trial. #ENDO2023@TheEndoSociety https://t.co/vsbX38CQkC
Of all the many minerals in your body, calcium is the one you have the most of. Find out how much of it you need and how to get it through your diet: https://t.co/CwIgFjBcwk
During a Senate hearing in May on insulin prices, Sen. Bernie Sanders pointed out how pharmaceutical companies have sold the exact same product for decades but continued raising prices in the U.S.
Inpefa (sotagliflozin) is a new dual drug recently approved by the FDA for heart failure. In trial results, sotagliflozin was shown to lower the risk of death, hospitalization, and urgent care visits associated with heart failure. Read More - https://t.co/E5JnRqFIN5